Epigenetic SMAD3 repression in tumor-associated fibroblasts impairs fibrosis and response to the antifibrotic drug nintedanib in lung squamous cell carcinoma

Journal: Cancer Research

Published: 2020-01-15

DOI: 10.1158/0008-5472.can-19-0637

Affiliations: 18

Authors: 23

Go to article
Institutions Share
Department of Biomedicine, UB, Spain 0.28
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain 0.14
Josep Carreras Leukaemia Research Institute (IJC), Spain 0.10
Faculty of Medicine and Health Sciences, UB, Spain 0.07
Vall d'Hebron Institute of Oncology (VHIO), HUVH ICS, Spain 0.06
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Spain 0.06
Boehringer Ingelheim RCV GmbH & Co. KG, Austria 0.04
Hospital Clinic of Barcelona, Spain 0.04
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain 0.04
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Spain 0.03
Catalan Institution for Research and Advanced Studies (ICREA), Spain 0.03
Division of Molecular Pathology, NKI, Netherlands 0.02
Oncode Institute, Netherlands 0.02
Center for Applied Medical Research (CIMA), UNAV, Spain 0.02
Corporació Sanitària Parc Taulí (CSPT), Spain 0.02
Department of Biochemistry and Molecular Biology, UAB, Spain 0.01
Institute of Bioengineering of Catalonia (IBEC), BIST, Spain 0.01
Department of Physiological Sciences II, UB, Spain 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER